{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:00:41Z","timestamp":1789592441715,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013826","name":"Candys Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005111","name":"Copenhagen University Hospital","doi-asserted-by":"publisher","award":["2020-352"],"award-info":[{"award-number":["2020-352"]}],"id":[{"id":"10.13039\/501100005111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejca.2024.113983","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T21:25:35Z","timestamp":1709328335000},"page":"113983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas"],"prefix":"10.1016","volume":"202","author":[{"given":"Amanda-Louise Fenger","family":"Carlander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Kloch","family":"Bendtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob H.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrine Kronberg","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Garset-Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gr\u00f8nh\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe","family":"Friborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hutcheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton D.","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyin","family":"Babarinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil D.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"von Buchwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejca.2024.113983_bib1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"issue":"36","key":"10.1016\/j.ejca.2024.113983_bib2","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1200\/JCO.2013.50.3870","article-title":"Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers","volume":"31","author":"Chaturvedi","year":"2013","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2024.113983_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/v13071326","article-title":"A contemporary systematic review on repartition of HPV-positivity in oropharyngeal cancer worldwide","volume":"13","author":"Carlander","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejca.2024.113983_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(23)00013-X","article-title":"Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis","author":"Mehanna","year":"2023","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2024.113983_bib5","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","article-title":"Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS\u2013ESMO\u2013ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Machiels","year":"2020","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2024.113983_bib6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ejca.2024.113983_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174292","article-title":"Report on late toxicity in head-and-neck tumor patients with long term survival after radiochemotherapy","volume":"13","author":"Buchberger","year":"2021","journal-title":"Cancers"},{"issue":"10166","key":"10.1016\/j.ejca.2024.113983_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet (Lond Engl)"},{"issue":"6","key":"10.1016\/j.ejca.2024.113983_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamaoncol.2022.0615","article-title":"Assessment of toxic effects and survival in treatment deescalation with radiotherapy vs transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma: the ORATOR2 Phase 2 Randomized Clinical Trial","volume":"8","author":"Palma","year":"2022","journal-title":"JAMA Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2024.113983_bib10","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/ijc.33893","article-title":"Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer","volume":"150","author":"Garset-Zamani","year":"2022","journal-title":"Int J Cancer"},{"issue":"32","key":"10.1016\/j.ejca.2024.113983_bib11","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2024.113983_bib12","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"issue":"July","key":"10.1016\/j.ejca.2024.113983_bib13","first-page":"1","article-title":"A high and increasing HPV prevalence in tonsillar cancers in Eastern Denmark, 2000-2010: the largest registry-based study to date","volume":"00","author":"Garnaes","year":"2014","journal-title":"Int J Cancer J Int du Cancer"},{"key":"10.1016\/j.ejca.2024.113983_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejca.2016.10.015","article-title":"Continuing rise in oropharyngeal cancer in a high HPV prevalence area: a Danish population-based study from 2011 to 2014","volume":"70","author":"Carlander","year":"2017","journal-title":"Eur J Cancer"},{"issue":"2020","key":"10.1016\/j.ejca.2024.113983_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2020.04.027","article-title":"The current epidemic of HPV-associated oropharyngeal cancer: an 18-year Danish population-based study with 2,169 patients","volume":"134","author":"Zamani","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2024.113983_bib16","unstructured":"Dansk Selskab for Hoved- og Hals Onkologi (DSHHO) DDHHCG (DAHANCA). Nationale Retningslinjer for Udredning, Behandling, Rehabilitering og Kontrolforl\u00f8b for Patienter med Pharynx- og Larynx-cancer i Danmark; 2011;(april):1\u201369."},{"key":"10.1016\/j.ejca.2024.113983_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.radonc.2020.07.037","article-title":"The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines","volume":"151","author":"Jensen","year":"2020","journal-title":"Radiother Oncol: J Eur Soc Ther Radiol Oncol"},{"key":"10.1016\/j.ejca.2024.113983_bib18","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Head and Neck Cancers; 2023;(Version 2.2023)."},{"issue":"12","key":"10.1016\/j.ejca.2024.113983_bib19","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.ejso.2018.05.022","article-title":"Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric study","volume":"44","author":"Culi\u00e9","year":"2018","journal-title":"Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"33","key":"10.1016\/j.ejca.2024.113983_bib20","article-title":"Novel nomograms for survival and progression in HPV+ and HPV- oropharyngeal cancer: a population-based study of 1,542 consecutive patients","volume":"7","author":"Larsen","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ejca.2024.113983_bib21","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.hoc.2008.10.002","article-title":"Human papillomavirus in HNSCC: a European epidemiologic perspective","volume":"22","author":"Licitra","year":"2008","journal-title":"Hematol Oncol Clin N Am"},{"issue":"8","key":"10.1016\/j.ejca.2024.113983_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/ijc.33876","article-title":"Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts","volume":"150","author":"Lassen","year":"2022","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.ejca.2024.113983_bib23","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.20.03128","article-title":"Reduced-dose radiation therapy for HPV-associated oropharyngeal carcinoma (NRG Oncology HN002)","volume":"39","author":"Yom","year":"2021","journal-title":"J Clin Oncol: J Am Soc Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2024.113983_bib24","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2021.04.015","article-title":"Randomized trial of radiation therapy with weekly cisplatin or cetuximab in low-risk hpv-associated oropharyngeal cancer (TROG 12.01) - a trans-tasman radiation oncology group study","volume":"111","author":"Rischin","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10166","key":"10.1016\/j.ejca.2024.113983_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet (Lond Engl)"},{"issue":"2","key":"10.1016\/j.ejca.2024.113983_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/cncr.30255","article-title":"National patterns of care and predictors of neoadjuvant and concurrent chemotherapy use with definitive radiotherapy in the treatment of patients with oropharyngeal squamous cell carcinoma","volume":"123","author":"Sher","year":"2017","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2024.113983_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol: J Eur Soc Ther Radiol Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2024.113983_bib28","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.oraloncology.2012.06.014","article-title":"Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis","volume":"48","author":"Ma","year":"2012","journal-title":"Oral Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2024.113983_bib29","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1002\/cncr.33491","article-title":"Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation","volume":"127","author":"Guo","year":"2021","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2024.113983_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(97)00220-X","article-title":"A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85","volume":"46","author":"Overgaard","year":"1998","journal-title":"Radiol Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2024.113983_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.radonc.2009.10.008","article-title":"HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer","volume":"94","author":"Lassen","year":"2010","journal-title":"Radiol Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2024.113983_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.24774","article-title":"The impact of health insurance status on the survival of patients with head and neck cancer","volume":"116","author":"Kwok","year":"2010","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.ejca.2024.113983_bib33","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/lary.26713","article-title":"Insurance status as a predictor of mortality in patients undergoing head and neck cancer surgery","volume":"127","author":"Rohlfing","year":"2017","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.ejca.2024.113983_bib34","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/jamaoto.2017.0837","article-title":"Association of insurance and community-level socioeconomic status with treatment and outcome of squamous cell carcinoma of the pharynx","volume":"143","author":"Shin","year":"2017","journal-title":"JAMA Otolaryngol-- Head Neck Surg"},{"issue":"12","key":"10.1016\/j.ejca.2024.113983_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.45510","article-title":"Association of smoking, comorbidity, clinical stage, and treatment intent with socioeconomic differences in survival after oropharyngeal squamous cell carcinoma in Denmark","volume":"5","author":"Olsen","year":"2022","journal-title":"JAMA Netw Open"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924001394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804924001394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:09:37Z","timestamp":1727395777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804924001394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":35,"alternative-id":["S0959804924001394"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2024.113983","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2024.113983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"113983"}}